Regulation of natural killer cell activation: implementation for the control of tumor metastasis

Natural Immunity and Cell Growth Regulation
|January 1, 1983
PubMed

Insights

Biological response modifiers (BRM) transiently activate natural killer (NK) cells. Subsequent NK cell hyporesponsiveness, linked to suppressor macrophage activation, impairs antimetastatic activity.

Area of Science:

  • Immunology
  • Cancer Research
  • Cellular Biology

Background:

  • Natural killer (NK) cells are crucial for anti-metastatic activity.
  • Biological response modifiers (BRM) can modulate NK cell function.
  • Understanding NK cell regulation by BRM is vital for cancer therapy.

Purpose of the Study:

  • To investigate the cellular interactions governing NK cell cytotoxicity and antimetastatic effects induced by BRM.
  • To elucidate the mechanisms behind NK cell hyporesponsiveness following BRM treatment.
  • To identify BRM strategies that maintain NK cell activation for sustained anti-tumor effects.

Main Methods:

  • Studied cellular interactions regulating NK cell-mediated cytotoxicity and antimetastatic activity.
  • Administered Corynebacterium parvum (C. parvum) as a BRM to induce NK cell activation and subsequent hyporesponsiveness.
  • Investigated the role of suppressor macrophages in NK cell hyporesponsiveness.
  • Evaluated the efficacy of BRM that selectively activate NK cells without activating suppressor macrophages.

Main Results:

  • A single C. parvum injection transiently activates NK cells, followed by a refractory period with depressed NK cell activity.
  • During hyporesponsiveness, BRM-induced antimetastatic activity is significantly reduced and not enhanced by multiple BRM injections.
  • NK cell hyporesponsiveness correlates with C. parvum-induced suppressor macrophage activation.
  • BRM selectively activating NK cells without suppressor macrophage activation prevent hyporesponsiveness and maintain anti-metastatic potential.

Conclusions:

  • NK cell activation by certain BRM is transient and can lead to hyporesponsiveness.
  • Suppressor macrophages play a key role in mediating this BRM-induced NK cell hyporesponsiveness.
  • BRM that avoid suppressor macrophage activation offer a promising strategy for sustained NK cell-mediated anti-metastatic therapy.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...